Emergency treatment of acute inferior wall myocardial infarction at three months after kidney transplantation: one case report
-
摘要: 本文报道1例肾移植术后3个月突发急性下壁ST段抬高型心肌梗死行急诊经皮冠状动脉介入治疗的患者。患者因“发作性胸闷胸痛1周,再发加重4 h”入院,经急诊经皮冠脉介入治疗及个体化药物治疗,5 d后病情稳定出院。Abstract: This article reported that the case suffered from acute inferior wall ST-segment elevation myocardial infarction and underwent emergency percutaneous coronary intervention at 3 months after kidney transplantation. The patient had episodic chest tightness and chest pain for 1 week and was admitted to the hospital. When the chest pain worsened again during the observation period, the emergency percutaneous coronary intervention was performed. After individualized drug treatment, the patient was discharged in stable condition 5 days after operation.
-
-
[1] 周康康, 张均玉, 周红卫. 终末期肾病患者死亡原因及危险因素分析[J]. 临床肾脏病杂志, 2018, 18(4): 224-228. doi: 10.3969/j.issn.1671-2390.2018.04.007
[2] Kasiske BL, Maclean JR, Snyder JJ. Acute myocardial infarction and kidney transplantation[J]. J Am Soc Nephrol, 2006, 17(3): 900-907. doi: 10.1681/ASN.2005090984
[3] Karthikeyan V, Ananthasubramaniam K. Coronary risk assessment and management options in chronic kidney disease patients prior to kidney transplantation[J]. Curr Cardiol Rev, 2009, 5(3): 177-186. doi: 10.2174/157340309788970342
[4] Deeb M, Gupta N, Overgaard CB, et al. Early postoperative acute myocardial infarction in kidney transplant recipients: A nested case-control study[J]. Clin Transplant, 2021, 35(5): e14283.
[5] 中华医学会器官移植学分会. 肾移植术后移植物功能延迟恢复诊疗技术规范(2019版)[J]. 器官移植, 2019, 10(5): 521-525. doi: 10.3969/j.issn.1674-7445.2019.05.010
[6] 刘夙璇, 秦永文, 陈峰, 等. 肾移植患者冠状动脉造影及介入治疗的临床应用(附6例报告)[J]. 第二军医大学学报, 2013, 34(1): 41-45. https://www.cnki.com.cn/Article/CJFDTOTAL-DEJD201301011.htm
[7] 杨爽, 王力宁. 影响他克莫司浓度的药物遗传学研究进展[J]. 临床肾脏病杂志, 2020, 20(9): 752-757. doi: 10.3969/j.issn.1671-2390.2020.09.013
[8] 赵瑞, 王华光, 崔向丽, 等. 临床药师对异体肾移植状态伴发急性心肌梗死患者的药学监护[J]. 中国临床药理学杂志, 2018, 34(14): 1693-1695. https://www.cnki.com.cn/Article/CJFDTOTAL-GLYZ201814031.htm
[9] 史天陆, 孙言才, 沈爱宗, 等. 他克莫司临床不良反应与防治[J]. 中国医院用药评价与分析, 2009, 9(1): 67-69. https://www.cnki.com.cn/Article/CJFDTOTAL-YYPF200901026.htm
[10] Kidney Disease: Improving Global Outcomes(KDIGO)Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients[J]. Am J Transplant, 2009, 9 Suppl 3: S1-155.
[11] Wiggins BS, Saseen JJ, Page RL 2nd, et al. Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association[J]. Circulation, 2016, 134(21): e468-e495.
[12] Lee T, D'Souza K, Hameed A, et al. Comparison of the effect of single vs dual antiplatelet agents on post-operative haemorrhage after renal transplantation: A systematic review and meta-analysis[J]. Transplant Rev(Orlando), 2021, 35(1): 100594. doi: 10.1016/j.trre.2020.100594
[13] Benkö T, Gottmann M, Radunz S, et al. One-year Allograft and Patient Survival in Renal Transplant Recipients Receiving Antiplatelet Therapy at the Time of Transplantation[J]. Int J Organ Transplant Med, 2018, 9(1): 10-19.
[14] Levine GN, Bates ER, Bittl JA, et al. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease[J]. J Am Coll Cardiol, 2016, 68(10): 1082-1115.